Predictors of premature termination from psychotherapy for anorexia nervosa: Low treatment credibility, early therapy alliance, and self‐transcendence. Issue 8 (29th May 2017)

• Record Type: Journal Article
• Authors: Jordan, Jennifer; McIntosh, Virginia V. W.; Carter, Frances A.; Joyce, Peter R.; Frampton, Christopher M. A.; Luty, Suzanne E.; McKenzie, Janice M.; Carter, Janet D.; Bulik, Cynthia M.
• Is Part Of: International journal of eating disorders. Volume 50:Issue 8(2017)
• Page Start: 979
• Page End: 983
• Publication Date: 2017-05-29
• Subjects: anorexia nervosa -- drop out -- premature termination -- self‐transcendence -- therapy alliance -- treatment credibility; Appetite disorders -- Periodicals; Ingestion disorders -- Periodicals; Eating disorders -- Periodicals; 616.8526
• DOI: 10.1002/eat.22726
• Languages: English
• ISSNs: 0276-3478

Abstract

Abstract: Objective: Failure to complete treatment for anorexia nervosa (AN) is‐ common, clinically concerning but difficult to predict. This study examines whether therapy‐related factors (patient‐rated pretreatment credibility and early therapeutic alliance) predict subsequent premature termination of treatment (PTT) alongside self‐transcendence (a previously identified clinical predictor) in women with AN. Methods: 56 women aged 17–40 years participating in a randomized outpatient psychotherapy trial for AN. Treatment completion was defined as attending 15/20 planned sessions. Measures were the Treatment Credibility, Temperament and Character Inventory, Vanderbilt Therapeutic Alliance Scale and the Vanderbilt Psychotherapy Process Scale. Statistics were univariate tests, correlations, and logistic regression. Results: Treatment credibility and certain early patient and therapist alliance/process subscales predicted PTT. Lower self‐transcendence and lower early process accounted for 33% of the variance in predicting PTT. Discussion: Routine assessment of treatment credibility and early process (comprehensively assessed from multiple perspectives) may help clinicians reduce PTT thereby enhancing treatment outcomes.